(Q46018859)

English

Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention.

scientific article published in March 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

Anterior nongranulomatous uveitis after intravitreal HPMPC (cidofovir) for the treatment of cytomegalovirus retinitis. Analysis and prevention. (English)

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

1 reference

based on heuristic

inferred from title

author name string

E Chavez-de la Paz

1

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

J F Arevalo

2

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

L S Kirsch

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

D Munguia

4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

F M Rahhal

5

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

E De Clercq

6

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

W R Freeman

7

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

publication date

1 March 1997

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

104

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

3

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

539-544

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired immune deficiency syndrome. Ocular manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cytomegalovirus retinopathy in patients with acquired immunodeficiency syndrome. Use of the experimental drug 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraocular antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreal ganciclovir in CMV retinitis: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravenous and intraocular ganciclovir for CMV retinitis in patients with AIDS or chemotherapeutic immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreal Sustained-Release Ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative inhibitory effects of nucleoside analogues on different clinical isolates of human cytomegalovirus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) against guinea pig cytomegalovirus infection in cultured cells and in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiviral activity and mechanism of action of ganciclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II study of intravitreal cidofovir for the treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Signs and symptoms of uveitis. I. Anterior uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Serious complications of topical mitomycin-C after pterygium surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cocaine-induced iritis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Systemic sulfonamides as a cause of bilateral, anterior uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

New developments in the treatment of CMV retinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2897%2930278-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(97)30278-4

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

1 reference

Europe PubMed Central

18 December 2017

http://europepmc.org/abstract/MED/9082286

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46018859&oldid=1400712651"